Help curb Alzheimer’s disease by participating in clinical trials

Adventist Health Castle

When you or someone you love is diagnosed with Alzheimer’s Disease or Alzheimer’s Dementia, your world can be turned upside down. It’s a progressive disease where symptoms such as memory loss, thinking and behavior problems develop slowly and get worse as time goes by. Host Jobeth Devera sat down with neurologist Dr. Kore Liow, chief of medicine at Adventist Health Castle, to find out more about Alzheimer’s and who is at risk.

Conditions that increase a person’s risk of developing cardiovascular disease, including high blood pressure, diabetes and high cholesterol, also increase his or her risk of developing Alzheimer’s. Also, if the disease runs in your family, it increases your risk as genetics can play a big part. And while Alzheimer’s can impair mental functions and interfere with daily tasks, Dr. Liow shares some things you can do reduce your risks, which includes participating in clinical trials offered at Adventist Health Castle.

About Dr. Kore Liow
Dr. Liow is the Chief of Medicine at Adventist Health Castle and Clinical Professor of Neurology at the University of Hawaii John Burns School of Medicine.  He is the founder of Hawaii’s largest provider of neuroscience (and memory) care at Hawaii Pacific Neuroscience where he leads a team of 10 physicians and scientists serving over 27,000 clinical visits and over 300 research visits last year from all Islands in 2017. The first of its kind Memory Disorders Center at Hawaii Pacific Neuroscience is the only facility in Hawaii with a dedicated multidisciplinary team of geriatrician, neurologists, psychologists, neuropsychologists and brain health and wellness specialists trained in diagnosing and treating memory disorders and dementia. Specialists work closely with researchers at the Alzheimer’s Research Center who are collaborating with scientists from around the world to find cure and better treatments for Alzheimer’s. They are currently 1 of 40 top dementia centers in the U.S. looking at potential disease modifying therapies like the Hawaii Alzheimer’s Prevention Initiative, Genematch Program in collaboration with University of Pennsylvania and the NIH/NIA Global GeneMatch program for patients with Early Alzheimer’s or those with no memory loss but at risk due to family history of Alzheimer’s for potential prevention therapies.

For more information: